The legacy of Viagra and the medicinal industry presents a challenging picture for careful investors. Initially, copyright's hugely successful drug transformed the treatment of erectile dysfunction, generating substantial profits and influencing the current pharmaceutical landscape. However, patent expiration and the emergence of off-brand versions